Long-Term Effect of Epirubicin on Incidence of Heart Failure in Women With Breast Cancer: Insight from a Randomized Clinical Trial

Abstract

Anthracycline-based chemotherapy is associated with a three-fold increased risk of late-onset clinical HF relative to non-anthracycline chemotherapy in this randomized clinical trial, but overall risk is low.